Providing closed system solutions for the last stages of your bioprocess.
The sterile bulk fill operation for active pharmaceutical ingredient (API) and bulk drug substance (BDS) remains one of the most critical processes in biopharmaceutical manufacturing. This late-stage process has potential safety impacts to the end user. After a drug is bulk filled in a cleanroom, there are few safeguards to ensure its sterility. Partnering with us, we can make products to fit your operation and protect end-stage bulk drug products while significantly reducing cost and risk.
We offer a variety of single-use products and instruments used in the fill/finish process including our cold temperature compatible Aramus™ bag assemblies, mixing systems, custom tube sets and manifolds, as well as particle characterization and concentration instruments. We can configure them to fit your application requirements, providing closed system solutions for the last stages of your bioprocess. We partner with you in the design and configuration of bulk fill solutions and provide expertise to assure supply, quality, and timely delivery.